Physician profile
Robert G Karman
NPI 1326660135
$2,106.85
in general payments reported to CMS, 2019-2025
14 companies · $820 in 2025
The $820 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,287 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,106.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $941.01 | 2024-2025 | 7 X 23mm Citrelock Implant, Augment Injectable, Variax |
| Smith+Nephew, INC. | $176.21 | 2024 | Oasis, Grafix, Collagenase Santyl |
| Advanced Oxygen Therapy INC. | $170.85 | 2024 | Topical Oxygen Chamber For Extremities |
| Integra Lifesciences Corporation | $166.32 | 2024 | Tcc-Ez |
| Kerecis Limited | $149.50 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Polynovo North America LLC | $146.43 | 2024 | Novosorb Btm |
| Solventum Corporation | $125.71 | 2024 | V.A.C. Veraflo, Prevena, V.A.C. Dermatac |
| Biocomposites INC | $94.93 | 2025 | Stimulan |
| Treace Medical Concepts, INC. | $39.42 | 2025 | |
| Bioventus LLC | $22.45 | 2024 | Exogen Ultrasound Bone Healing System |
| Collegium Pharmaceutical, INC. | $20.51 | 2025 | Xtampza |
| Polaris Technology Solutions LLC | $19.11 | 2025 | |
| Abbvie INC. | $18.57 | 2024 | |
| Medartis INC. | $15.83 | 2024 | Aptus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Karman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.